| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A multicenter analysis of GTX chemotherapy in patients with locally advanced and metastatic pancreatic adenocarcinoma
|
De Jesus-Acosta, Ana
|
|
2011
|
69 |
2 |
p. 415-424
|
artikel
|
| 2 |
A multicenter phase II study of combined chemotherapy with docetaxel, cisplatin, and S-1 in patients with unresectable or recurrent gastric cancer (KDOG 0601)
|
Koizumi, Wasaburo
|
|
2011
|
69 |
2 |
p. 407-413
|
artikel
|
| 3 |
An all-oral combination of metronomic cyclophosphamide plus capecitabine in patients with anthracycline- and taxane-pretreated metastatic breast cancer: a phase II study
|
Wang, Zhonghua
|
|
2011
|
69 |
2 |
p. 515-522
|
artikel
|
| 4 |
A phase I study of 5-azacytidine and erlotinib in advanced solid tumor malignancies
|
Bauman, Julie
|
|
2011
|
69 |
2 |
p. 547-554
|
artikel
|
| 5 |
A phase I study of bortezomib and temozolomide in patients with advanced solid tumors
|
Portnow, J.
|
|
2011
|
69 |
2 |
p. 505-514
|
artikel
|
| 6 |
A phase I study of bortezomib and temozolomide in patients with advanced solid tumors
|
Portnow, J.
|
|
|
69 |
2 |
p. 505-514
|
artikel
|
| 7 |
A randomised phase II trial of two sequential schedules of docetaxel and cisplatin followed by gemcitabine in patients with advanced non-small-cell lung cancer
|
Grossi, Francesco
|
|
2011
|
69 |
2 |
p. 369-375
|
artikel
|
| 8 |
Chemotherapy with gemcitabine, cisplatin, and docetaxel in the treatment for patients with muscle-invasive bladder cancer: a multicenter phase II study of the Hellenic Oncology Research Group (HORG)
|
Boukovinas, Ioannis
|
|
2011
|
69 |
2 |
p. 351-356
|
artikel
|
| 9 |
Docetaxel plus gemcitabine in combination with capecitabine as treatment for inoperable pancreatic cancer: a phase II study
|
Xenidis, N.
|
|
2011
|
69 |
2 |
p. 477-484
|
artikel
|
| 10 |
Dose adaptation of capecitabine based on individual prediction of limiting toxicity grade: evaluation by clinical trial simulation
|
Paule, Ines
|
|
2011
|
69 |
2 |
p. 447-455
|
artikel
|
| 11 |
Doxorubicin and ifosfamide for high-grade sarcoma during pregnancy
|
Mir, Olivier
|
|
2011
|
69 |
2 |
p. 357-367
|
artikel
|
| 12 |
Effect of trabectedin on the QT interval in patients with advanced solid tumor malignancies
|
Thertulien, R.
|
|
2011
|
69 |
2 |
p. 341-350
|
artikel
|
| 13 |
Imatinib mesylate in thymic epithelial malignancies
|
Palmieri, Giovannella
|
|
2011
|
69 |
2 |
p. 309-315
|
artikel
|
| 14 |
Inhibition of glutathione synthesis reverses Krüppel-like factor 4-mediated cisplatin resistance
|
Jia, Yongsheng
|
|
2011
|
69 |
2 |
p. 377-385
|
artikel
|
| 15 |
Intratumor heterogeneity and chemotherapy-induced changes in EGFR status in non-small cell lung cancer
|
Jakobsen, Jan Nyrop
|
|
2011
|
69 |
2 |
p. 289-299
|
artikel
|
| 16 |
Matrine induces caspase-dependent apoptosis in human osteosarcoma cells in vitro and in vivo through the upregulation of Bax and Fas/FasL and downregulation of Bcl-2
|
Liang, Cheng Zhen
|
|
2011
|
69 |
2 |
p. 317-331
|
artikel
|
| 17 |
Nrf2 knockdown by shRNA inhibits tumor growth and increases efficacy of chemotherapy in cervical cancer
|
Ma, Xiangdong
|
|
2011
|
69 |
2 |
p. 485-494
|
artikel
|
| 18 |
Nucleoside transporters are widely expressed in ovarian carcinoma effusions
|
Bock, Annika J.
|
|
2011
|
69 |
2 |
p. 467-475
|
artikel
|
| 19 |
Oral fludarabine in combination with doxorubicin and dexamethasone as first-line therapy for nodal peripheral T-cell lymphomas: early results of a prospective multicenter study
|
Liu, Xiao-Jian
|
|
2011
|
69 |
2 |
p. 387-395
|
artikel
|
| 20 |
Oral fludarabine in combination with doxorubicin and dexamethasone as first-line therapy for nodal peripheral T-cell lymphomas: early results of a prospective multicenter study
|
Liu, Xiao-Jian
|
|
|
69 |
2 |
p. 387-395
|
artikel
|
| 21 |
Oxidative damage to guanine nucleosides following combination chemotherapy with 5-fluorouracil and oxaliplatin
|
Afzal, Shoaib
|
|
2011
|
69 |
2 |
p. 301-307
|
artikel
|
| 22 |
Phase I and pharmacokinetic study of nab-paclitaxel, nanoparticle albumin-bound paclitaxel, administered weekly to Japanese patients with solid tumors and metastatic breast cancer
|
Ando, Masashi
|
|
2011
|
69 |
2 |
p. 457-465
|
artikel
|
| 23 |
Phase I and pharmacokinetic study of nab-paclitaxel, nanoparticle albumin-bound paclitaxel, administered weekly to Japanese patients with solid tumors and metastatic breast cancer
|
Ando, Masashi
|
|
|
69 |
2 |
p. 457-465
|
artikel
|
| 24 |
Phase IB study of sorafenib in combination with gemcitabine and cisplatin in patients with refractory solid tumors
|
Schultheis, B.
|
|
2011
|
69 |
2 |
p. 333-339
|
artikel
|
| 25 |
Phase I dose escalation study of KOS-1584, a novel epothilone, in patients with advanced solid tumors
|
Lam, Elaine T.
|
|
2011
|
69 |
2 |
p. 523-531
|
artikel
|
| 26 |
Phase I study of cediranib in combination with cisplatin plus fluoropyrimidine (S-1 or capecitabine) in Japanese patients with previously untreated advanced gastric cancer
|
Satoh, Taroh
|
|
2011
|
69 |
2 |
p. 439-446
|
artikel
|
| 27 |
Phase I study of the synthetic triterpenoid, 2-cyano-3, 12-dioxoolean-1, 9-dien-28-oic acid (CDDO), in advanced solid tumors
|
Speranza, Giovanna
|
|
2011
|
69 |
2 |
p. 431-438
|
artikel
|
| 28 |
Physiologically based pharmacokinetic modelling of high- and low-dose etoposide: from adults to children
|
Kersting, Gisela
|
|
2011
|
69 |
2 |
p. 397-405
|
artikel
|
| 29 |
Probenecid is a chemosensitizer in cancer cell lines
|
Campos-Arroyo, Denise
|
|
2011
|
69 |
2 |
p. 495-504
|
artikel
|
| 30 |
The effect of bexarotene on atorvastatin pharmacokinetics: results from a phase I trial of bexarotene plus chemotherapy in patients with advanced non-small cell lung cancer
|
Wakelee, Heather A.
|
|
2011
|
69 |
2 |
p. 563-571
|
artikel
|
| 31 |
The effect of food on the bioavailability of panobinostat, an orally active pan-histone deacetylase inhibitor, in patients with advanced cancer
|
Shapiro, Geoffrey I.
|
|
2011
|
69 |
2 |
p. 555-562
|
artikel
|
| 32 |
The use of GTX as second-line and later chemotherapy for metastatic pancreatic cancer: a retrospective analysis
|
Dakik, Hassan K.
|
|
2011
|
69 |
2 |
p. 425-430
|
artikel
|
| 33 |
Treatment of experimental extravasation of amrubicin, liposomal doxorubicin, and mitoxantrone with dexrazoxane
|
Langer, Seppo W.
|
|
2011
|
69 |
2 |
p. 573-576
|
artikel
|
| 34 |
Triple-negative phenotype is of adverse prognostic value in patients treated with dose-dense sequential adjuvant chemotherapy: a translational research analysis in the context of a Hellenic Cooperative Oncology Group (HeCOG) randomized phase III trial
|
Skarlos, P.
|
|
2011
|
69 |
2 |
p. 533-546
|
artikel
|
Tijdschrift beschrijving